financetom
Business
financetom
/
Business
/
Ziff Davis Enters $401 Million Convertible Note Exchange Deals
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ziff Davis Enters $401 Million Convertible Note Exchange Deals
Jul 10, 2024 5:42 AM

08:27 AM EDT, 07/10/2024 (MT Newswires) -- Ziff Davis ( ZD ) said Wednesday it has entered into agreements with certain holders to exchange about $401 million of its 1.75% convertible senior notes due 2026.

The company said that under these agreements, Ziff Davis ( ZD ) will exchange the notes for around $263 million in new 3.625% convertible senior notes due 2028 and about $135 million in cash.

After the exchange, expected to close by July 16, about $149 million of the existing notes will remain, and the new notes will total around $263 million, Ziff Davis ( ZD ) said.

The new notes will not generate any cash proceeds for the company and will bear interest at 3.625% per year, maturing on March 1, 2028, the company said. They can be converted into company stock under certain conditions, Ziff Davis ( ZD ) added.

Shares of the company were down 1.8% in recent Wednesday premarket activity.

Price: 50.94, Change: -0.92, Percent Change: -1.77

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Jul 26, 2024
07:32 AM EDT, 07/26/2024 (MT Newswires) -- William Richard White, Chief Financial Officer, around July 23, 2024, sold 161,855 shares in Akero Therapeutics ( AKRO ) for $4,381,867. Following the Form 4 filing with the SEC, White has control over a total of 41,791 shares of the company, with 41,791 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017024086659/xslF345X03/ownership.xml ...
Colgate-Palmolive Q2 Non-GAAP Earnings, Net Sales Rise; 2024 Non-GAAP EPS Guidance Raised
Colgate-Palmolive Q2 Non-GAAP Earnings, Net Sales Rise; 2024 Non-GAAP EPS Guidance Raised
Jul 26, 2024
07:26 AM EDT, 07/26/2024 (MT Newswires) -- Colgate-Palmolive ( CL ) reported Q2 non-GAAP earnings Friday of $0.91 per diluted share, up from $0.77 a year earlier. Analysts polled by Capital IQ expected $0.87. Net sales for the quarter ended June 30 were $5.06 billion, up from $4.82 billion a year earlier. Analysts polled by Capital IQ expected $5.0 billion....
Booz Allen Hamilton Fiscal Q1 Adjusted Earnings Fall, Revenue Rises; Fiscal 2025 Outlook Reaffirmed
Booz Allen Hamilton Fiscal Q1 Adjusted Earnings Fall, Revenue Rises; Fiscal 2025 Outlook Reaffirmed
Jul 26, 2024
07:31 AM EDT, 07/26/2024 (MT Newswires) -- Booz Allen Hamilton Holding ( BAH ) reported fiscal Q1 adjusted earnings Friday of $1.38 per diluted share, down from $1.47 a year earlier. Analysts polled by Capital IQ expected $1.52. Revenue for the quarter ended June 30 was $2.94 billion, compared with $2.65 billion a year earlier. Analysts surveyed by Capital IQ...
Balchem's Q2 Earnings, Net Sales Rise
Balchem's Q2 Earnings, Net Sales Rise
Jul 26, 2024
07:32 AM EDT, 07/26/2024 (MT Newswires) -- Balchem ( BCPC ) reported Q2 adjusted earnings Friday of $1.09 per diluted share, up from $1.06 a year earlier. Two analysts surveyed by Capital IQ expected $1.04. Net sales for the quarter ended June 30 was $234.1 million, compared with $231.3 million a year earlier. Three analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved